Article Information
History
- January 23, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Marina Siirin1,
- Bijan Pedram1,
- Maria J. Gonzalez-Moa1,
- Louisa Warryn2,3,
- Rie Yotsu4,5,
- Jean M. Saunders1,
- Aaron E. Saunders6,
- Richard K. Baldwin6,
- Jessica L. Porter7,
- Timothy P. Stinear7,
- Israel Cruz-Mata8,9,
- Dziedzom Komi de Souza8,10,
- Gerd Pluschke2,3 and
- Marco A. Biamonte1,*
- 1Drugs & Diagnostics for Tropical Diseases, San Diego, California, United States of America
- 2Swiss Tropical and Public Health Institute, Allschwil, Switzerland
- 3University of Basel, Basel, Switzerland
- 4School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
- 5Department of Tropical Medicine, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America
- 6NanoComposix, a Fortis Life company, San Diego, California, United States of America
- 7Department of Microbiology and Immunology, Doherty Institute, University of Melbourne, Victoria, Australia
- 8Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland
- 9National School of Public Health, CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain
- 10Noguchi Memorial Institute, Accra, Ghana
- ↵* Corresponding author; email: marco.biamonte{at}ddtd.org